Sunday 10 June 2012

Breast Cancer-Roche Holding

FDA Approves Roche Breast Cancer Drug

The FDA approved a new drug to treat women with advanced cases of a specific type of breast cancer. Perjeta, was developed by Roche Holding's Genentech unit to treat women whose breast cancer tests positive for protein called HER2 and has spread beyond the breast. (Source: Health) read more..

No comments:

Post a Comment